Recombinant expression vector for producing highly-expressed human serum albumin, host strain, and use of host strain
AssigneeHebei Huakai Huihe Biomedical Co., Ltd.
InventorsZhimin LIU, Kanghua WU
Life of this patent
Estimating the term…
Loading patent…
AssigneeHebei Huakai Huihe Biomedical Co., Ltd.
InventorsZhimin LIU, Kanghua WU
Estimating the term…
A recombinant expression vector for producing highly expressed human serum albumin (HSA), a host strain, and a use of the host strain are provided. Through the optimization design for the target gene, the construction of a Pichia pastoris engineered strain carrying the exogenous gene with a high copy number and expressing the exogenous gene at a high level, and the optimization of a pilot-scale fermentation process, an expression level of the recombinant HSA can be as high as 25.82 g/L. A purification process for the recombinant HSA involves only fermentation broth pretreatment and three-step column chromatography, and enables a purity of 99% or more for the target protein. A recovery rate of the entire purification process reaches 60% or more.
A recombinant expression vector for producing highly-expressed human serum albumin (HSA), wherein the nucleotide sequence of the recombinant expression vector is shown in SEQ ID NO:
A host strain for high-level expression of HSA, wherein the host strain is Pichia pastoris HSA-C16, wherein the Pichia pastoris HSA-C16 is deposited at China General Microbiological Culture Collection Center (CGMCC) with an accession number of CGMCC No. 30175, and a deposit date is Mar. 28, 2024.
Dependencies are inferred from the claim text.